Skip to content
naulon

Not checkedNot checked for notices yet.

<it>PTEN</it> genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

Choucair Khalil, Ejdelman Joshua, Brimo Fadi and 3 more

BMC Cancer · 2012

doi:10.1186/1471-2407-12-543 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Prostate cancer (PCa), a leading cause of cancer death in North American men, displays a broad range of clinical outcome from relatively indolent to lethal metastatic disease. Several genomic alterations have been identified in PCa which may serve as predictors of progression. <it>PTEN</it>, (10q23.3), is a negative regulator of the phosphatidylinositol 3-kinase (PIK3)/AKT survival pathway and a tumor suppressor frequently deleted in PCa. The androgen receptor (AR) signalling pathway is known to play an important role in PCa and its blockade constitutes a commonly used treatment modality. In this study, we assessed the deletion status of <it>PTEN</it> along with AR expression levels in 43 primary PCa specimens with clinical follow-up.</p> <p>Methods</p> <p>Fluorescence <it>In Situ</it> Hybridization (FISH) was done on formalin fixed paraffin embedded (FFPE) PCa samples to examine the deletion status of <it>PTEN</it>. AR expression levels were determined using immunohistochemistry (IHC).</p> <p>Results</p> <p>Using FISH, we found 18 cases of <it>PTEN</it> deletion. Kaplan-Meier analysis showed an association with disease recurrence (<it>P</it>=0.03). Concurrently, IHC staining for AR found significantly lower levels of AR expression within those tumors deleted for <it>PTEN</it> (<it>P</it><0.05). To validate these observations we interrogated a copy number alteration and gene expression profiling dataset of 64 PCa samples, 17 of which were <it>PTEN</it> deleted. We confirmed the predictive value of <it>PTEN</it> deletion in disease recurrence (<it>P</it>=0.03). <it>PTEN</it> deletion was also linked to diminished expression of PTEN (<it>P</it><0.01) and AR (<it>P</it>=0.02). Furthermore, gene set enrichment analysis revealed a diminished expression of genes downstream of AR signalling in <it>PTEN</it> deleted tumors.</p> <p>Conclusions</p> <p>Altogether, our data suggest that <it>PTEN</it> deleted tumors expressing low levels of AR may represent a worse prognostic subset of PCa establishing a challenge for therapeutic management.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.